GW PHARMACEUTICALS PLC (GWPH) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 304 transactions totaling $101.9M, demonstrating a bearish sentiment with -$101.8M in net insider flow. The most recent transaction on May 5, 2021 involved a transaction of 7,200 shares valued at $0.
No significant insider buying has been recorded for GWPH in the recent period.
No significant insider selling has been recorded for GWPH in the recent period.
Based on recent SEC filings, insider sentiment for GWPH is bearish with an Insider Alignment Score of 0/100 and a net flow of -$101.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GW PHARMACEUTICALS PLC (GWPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading GWPH stock, having executed 304 transactions in the past 90 days. The most active insider is Geoffrey W. Dr Guy (Executive), who has made 44 transactions totaling $60.8M.
Get notified when executives and directors at GWPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 5, 2021 | Brown Cabot | Executive | Disposition | 7,200 | $N/A | $0 | |
| May 5, 2021 | W. Dr Guy Geoffrey | Executive | Disposition | 103,925 | $N/A | $0 | |
| May 5, 2021 | W. Dr Guy Geoffrey | Executive | Disposition | 4,781,521 | $N/A | $0 | |
| May 5, 2021 | W. Dr Guy Geoffrey | Executive | Disposition | 25,000 | $N/A | $0 | |
| May 5, 2021 | D. Gover Justin | Executive | Disposition | 1,867,308 | $N/A | $0 | |
| May 5, 2021 | D. Gover Justin | Executive | Disposition | 222,773 | $N/A | $0 | |
| May 5, 2021 | D. Gover Justin | Executive | Disposition | 456,048 | $N/A | $0 | |
| May 5, 2021 | J. Mackey Catherine | Executive | Disposition | 10,536 | $N/A | $0 | |
| May 5, 2021 | M. Giacobello Scott | Executive | Disposition | 165,108 | $N/A | $0 | |
| May 5, 2021 | Secor Alicia | Executive | Disposition | 10,584 | $N/A | $0 | |
| May 5, 2021 | Knappertz Volker | Executive | Disposition | 92,412 | $N/A | $0 | |
| May 5, 2021 | Noble James | Executive | Disposition | 27,492 | $N/A | $0 | |
| May 5, 2021 | B. Snyder Douglas | Executive | Disposition | 61,848 | $N/A | $0 | |
| May 5, 2021 | S. Cline Darren | Executive | Disposition | 5,556 | $N/A | $0 | |
| May 5, 2021 | J. Tovey Christopher | Executive | Disposition | 2,496 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 148 | $101.9M | 88.4% |
Payment(F) | 28 | $9.0M | 7.8% |
Exercise(M) | 106 | $4.4M | 3.8% |
Purchase(P) | 1 | $49.0K | 0.0% |
Disposition(D) | 16 | $264 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Insider selling pressure at GW PHARMACEUTICALS PLC has increased, with 14 insiders executing 304 transactions across all time. Total sales of $101.9M significantly outpace purchases of $49.0K, resulting in a net outflow of $101.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.